Health
US vaccine firm: Human trials could be held in Israel as infection rates rise – The Times of Israel
After Jerusalem signed binding term sheet for purchase of drug, CEO of Arcturus Therapeutics says Phase 3 study needs to be held in location with substantial number of cases
The head of a US firm developing a COVID-19 vaccine said Sunday that as infection rates of the coronavirus rise in Israel, it could be used as a location for human trials.
“My understanding is that Israel is under some significant challenges with respect to the prevalence of COVID, and it would present an opportunity to perhaps do the registration study in Israel, combining that data with other countries as well,” Arcturus Therapeutics CEO Joseph Payne told Channel 12 news, referring to the Pha…
-
Noosa News12 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
General23 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
Noosa News22 hours agoE-Scooter accident | Noosa Today
-
General21 hours agoOutback Farm stars finish first barley harvest at Central Australian farm